HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
View All | Scroll Down Scroll Up
Quote:
Login Free Membership
Search:

Corporate Summary  

Company News for December 24, 2009

Share
By: Avishek Mishra
December 24, 2009 | Comment(s): 0
Recommended this article (6)
PFE | SNY | AAPL | GOOG

• Pfizer (NYSE:PFE - Analyst Report) Lyrica anti-anxiety drug was rejected by the FDA as data showed the drug was insufficient for treatment of anxiety disorder

• The FDA approved a new Sanofi-Aventis (NYSE:SNY - Analyst Report) high-dose, flu vaccine for individuals aged more than 65 years

• The Senate passed the healthcare package this morning by a vote of 60 to 39

• According to a news report, Apple (NASDAQ:AAPL - Analyst Report) has rented San Francisco space for late January in advance of a major product announcement, with its new tablet device rumored to be unveiled

• Google (NASDAQ:GOOG - Analyst Report) plans 150,000 applications by the end of next year

Read the full analyst report on PFE

Read the full analyst report on SNY

Read the full analyst report on AAPL

Read the full analyst report on GOOG

 

Please login to Zacks.com or register to post a comment.

Email
Print
Share
Rate Pos
Rate Neg
Attn. Zacks.com Visitors
7 Best Stocks for the Next 30 Days
Get your free Welcome Gifts today*:
 1.  Special Report with best short-term Zacks recommendations from the list that averages a gain of +26% per year
 2.  Our free e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

More Zacks Links

Market Summary May 26, 2012 04:43 am ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center

Top Zacks Features

Free Membership
Zacks Rank
Equity Research
Portfolio Tracker
Screening
Premium Screens
Mutual Funds
Options
Zacks Video
Education
RSS Feed
Profit from the Pros

Subscription Services

Product Guide
Method for Trading
Chart Patterns
FTM Trader
Home Run Investor
Income Plus
Insider Trader
Options Trader
Reitmeister Alert
Tactical Trader
Top 10 Stocks
Turnaround Trader
Whisper Trader
Research Wizard
People & Picks
Zacks Premium
Zacks Ultimate
Zacks.com: About Zacks | Education | Advertise | Affiliate | Media | Careers | Contact Us | Services | Help | Disclaimer | Privacy Policy | Sitemap

Copyright 2011 Zacks Investment Research

Zacks Investment Research is one of the most highly regarded firms in the investment industry. The guiding principle behind our work is that there must be a good reason for brokerage firms to spend billions of dollars a year on stock research. Obviously, these investment experts know something special that may be indicative of the future direction of stock prices. From day one, we were determined to unlock that secret knowledge and make it available to our clients to help them improve their investment results.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.